Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 22 of 24 for:    CD20 Fred Hutchinson

Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00250861
Recruitment Status : Terminated (Study terminated due to lack of enrollment.)
First Posted : November 8, 2005
Last Update Posted : April 21, 2008
Chiron Corporation
Fred Hutchinson Cancer Research Center
Information provided by:
US Oncology Research

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 2007
Actual Study Completion Date : August 2007